Payment overview · 2025
General Payments
$79.50
3 reported records · 2 companies
Healthcare provider profile · identity verified
Michael Curtis West, MD
Allopathic & Osteopathic Physicians|Family Medicine · IDABEL, OK · NPI 1649346545
Verified facts
What the public records show
CMS Open Payments records show Michael Curtis West, MD received $79.50 in general payments during 2025 across 3 reported records.
Dexcom, Inc. accounted for 64.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $50.92 | 64.0% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $28.58 | 36.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $79.50 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $50.92 | 2 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $28.58 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 423 | 126 |
| Atorvastatin Calcium | Atorvastatin Calcium | 324 | 100 |
| Potassium Chloride | Potassium Chloride | 293 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 286 | 75 |
| Furosemide | Furosemide | 273 | 90 |
| Omeprazole | Omeprazole | 270 | 85 |
| Gabapentin | Gabapentin | 263 | 84 |
| Lisinopril | Lisinopril | 239 | 70 |
| Losartan Potassium | Losartan Potassium | 203 | 69 |
| Carvedilol | Carvedilol | 201 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 194 | 59 |
| Metformin Hcl | Metformin Hcl | 182 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 180 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 167 | 46 |
| Meloxicam | Meloxicam | 162 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 156 | 50 |
| Montelukast Sodium | Montelukast Sodium | 151 | 45 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 148 | 37 |
| Tramadol Hcl | Tramadol Hcl | 146 | 47 |
| Pregabalin | Pregabalin | 140 | 35 |
| Eliquis | Apixaban | 137 | 26 |
| Azithromycin | Azithromycin | 136 | 109 |
| Simvastatin | Simvastatin | 130 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 125 | 40 |
| Jardiance | Empagliflozin | 115 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 113 | 31 |
| Trazodone Hcl | Trazodone Hcl | 113 | 30 |
| Alprazolam | Alprazolam | 107 | 24 |
| Clonazepam | Clonazepam | 107 | 20 |
| Allopurinol | Allopurinol | 105 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 44 |
| Memantine Hcl | Memantine Hcl | 104 | 27 |
| Prednisone | Prednisone | 103 | 39 |
| Tizanidine Hcl | Tizanidine Hcl | 103 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 102 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 92 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 24 |
| Lorazepam | Lorazepam | 86 | 22 |
| Famotidine | Famotidine | 85 | 25 |
| Sertraline Hcl | Sertraline Hcl | 83 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 18 |
| Temazepam | Temazepam | 79 | 19 |
| Diazepam | Diazepam | 76 | 17 |
| Ozempic | Semaglutide | 75 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 74 | 21 |
| Mounjaro | Tirzepatide | 73 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 22 |
| Donepezil Hcl | Donepezil Hcl | 72 | 22 |
| Ezetimibe | Ezetimibe | 68 | 21 |
| Glimepiride | Glimepiride | 67 | 13 |
| Baclofen | Baclofen | 65 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 65 | 43 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 64 | 21 |
| Risperidone | Risperidone | 60 | 13 |
| Estradiol | Estradiol | 58 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 15 |
| Celecoxib | Celecoxib | 56 | 17 |
| Spironolactone | Spironolactone | 56 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 55 | 49 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 54 | 48 |
| Mirtazapine | Mirtazapine | 53 | 13 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 53 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 53 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 14 |
| Amoxicillin | Amoxicillin | 50 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 50 | 14 |
| Levetiracetam | Levetiracetam | 50 | suppressed |
| Finasteride | Finasteride | 49 | 13 |
| Cefdinir | Cefdinir | 48 | 43 |
| Fentanyl | Fentanyl | 48 | 11 |
| Glipizide | Glipizide | 48 | 16 |
| Ibuprofen | Ibuprofen | 48 | 14 |
| Fluconazole | Fluconazole | 47 | 38 |
| Sucralfate | Sucralfate | 47 | 12 |
| Buspirone Hcl | Buspirone Hcl | 45 | 12 |
| Xarelto | Rivaroxaban | 45 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Cephalexin | Cephalexin | 42 | 33 |
| Ondansetron Odt | Ondansetron | 42 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | suppressed |
| Methylprednisolone | Methylprednisolone | 39 | 32 |
| Clonidine Hcl | Clonidine Hcl | 38 | 16 |
| Chlorthalidone | Chlorthalidone | 37 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 12 |
| Megestrol Acetate | Megestrol Acetate | 37 | suppressed |
| Primidone | Primidone | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | 17 |
| Phenobarbital | Phenobarbital | 33 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | suppressed |
| Tradjenta | Linagliptin | 33 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Mupirocin | Mupirocin | 31 | 21 |
| Topiramate | Topiramate | 31 | suppressed |
| Bumetanide | Bumetanide | 30 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Methocarbamol | Methocarbamol | 26 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 25 | 11 |
| Levofloxacin | Levofloxacin | 25 | 22 |
| Lovastatin | Lovastatin | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Nystatin | Nystatin | 24 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Brilinta | Ticagrelor | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 20 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 21 | 12 |
| Alendronate Sodium | Alendronate Sodium | 20 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Trimethoprim | Trimethoprim | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Valproic Acid | Valproic Acid | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | 11 |
| Promethazine Hcl | Promethazine Hcl | 18 | 14 |
| Rybelsus | Semaglutide | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 12 |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 15 | suppressed |
| Atenolol | Atenolol | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Kerendia | Finerenone | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | 13 |
| Linzess | Linaclotide | 13 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $79.50 · 3 records | Dexcom, Inc. | Dexcom G6 Transmitter, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error